World

EU balance for trade in goods hit €40.4 bn in Q2-24

Aug 27, 2024

Brussels [Belgium], August 27: The EU balance for trade in goods was €40.4 billion in the second quarter of 2024, down from €55.3 billion in the previous quarter, according to figures published by Eurostat, the statistical office of the European Union.
As such, the trade balance has now shown a surplus for 4 quarters in a row, following a period of deficits from the fourth quarter of 2021 to the second quarter of 2023, primarily due to a high deficit for energy offsetting surpluses in other product categories.
In the second quarter of 2024, the surpluses recorded in machinery and vehicles (€56.9 billion), chemicals and related materials (€59.3 billion), food and drink (€13.9 billion), other manufactured goods (€1.8 billion) and other goods (€3.2 billion) outweighed the deficits in energy (-€88.4 billion) and raw materials (-€6.3 billion).
In the second quarter of 2024, imports of goods from non-EU countries to the EU increased by 3.4 percent compared with the previous quarter, while exports were almost steady, rising 0.7 percent. Imports grew after having declined for 6 consecutive quarters, while export levels continued to go up for the third quarter in a row.
Source: Emirates News Agency

More news

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Mumbai (Maharashtra) [India]/ Iselin (New Jersey) [US], July 10: Hexaware Technologies, a global provider of IT services and solutions, today announced a strategic partnership with Abluva, an innovator in agentic AI security, to address security challenges posed by autonomous AI agents in the Life Sciences industry. This collaboration brings together Hexaware's deep domain expertise and Abluva's groundbreaking Secure Intelligence Plane to help organizations in the sector deploy generative AI (GenAI) safely and in compliance with industry regulations. As Life Sciences organizations increasingly adopt agentic AI to enhance research, clinical trials, patient data management, and commercial operations, the partnership ensures that AI agents operate in a secure, governed, and auditable environment--without hindering innovation. Delivering Governed and Secure Generative AI Agents for Life Sciences Innovation.

Jul 10, 2025